Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3385
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neuroscience, and gastrointestinal. Its cardiovascular and metabolic disease products include candesartan cilexetil, ticagrwlor, exenatide, rosuvastatin, felodipine, metoprolo succinate, pramlintide acetate, and atenolol, among others. AstraZeneca offers oncology products such as anastrozole tablets, tamoxifen tablets, gefitinib tablets, goserelin acetate injection, goserelin acetate depot injection, bicalutamide tablets, and fulvestrant injection. The company operates in China, Hong Kong, India, Singapore, Thailand, Canada, Chile, Colombia, Mexico, the US, and Mauritius, among others. AstraZeneca is headquartered in Bangalore, Karnataka, India.

Astrazeneca Pharma India Ltd (ASTRAZEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy’s Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Asset Transactions 13
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
Acquisition 14
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd – Key Competitors 15
Astrazeneca Pharma India Ltd – Key Employees 16
Astrazeneca Pharma India Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
May 09, 2017: AstraZeneca Pharma India Reports Total Income From Operations Of INR5.4 Billion In Fiscal 2017 18
Corporate Communications 19
Aug 08, 2017: AstraZeneca Appoints Mr. Ian John Parish to its Board of Director 19
Jun 29, 2017: AstraZeneca Announces Board Change 20
Other Significant Developments 21
May 17, 2018: AstraZeneca strengthens innovation partnership in India 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy's Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd, Key Competitors 15
Astrazeneca Pharma India Ltd, Key Employees 16

List of Figures
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Pennsylvania-製薬・医療分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kering SA (KER):企業の財務・戦略的SWOT分析
    Kering SA (KER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hyundai Corporation:企業の戦略・SWOT・財務分析
    Hyundai Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyundai Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • American Eagle Outfitters Inc:企業の戦略・SWOT・財務情報
    American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary American Eagle Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • NH Hotel Group, S. A. (NHH):企業の財務・戦略的SWOT分析
    NH Hotel Group, S. A. (NHH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • 2020 GeneSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of l …
  • Manhattan Construction Group:企業の戦略的SWOT分析
    Manhattan Construction Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) operates as a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers …
  • Pulmagen Therapeutics LLP:製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmagen Therapeutics LLP (Pulmagen) formerly Argenta Discovery Ltd, is a development stage pharmaceutical company, which develops oral and inhaled medicines for chronic respiratory diseases. The company’s product pipeline includes oral CRTh2 antagonists, inhaled bronchodilators, inhaled per …
  • Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company's proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to ide …
  • Murata Manufacturing Co., Ltd.:企業の戦略・SWOT・財務分析
    Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murata Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • McKesson Corporation:企業の戦略・SWOT・財務情報
    McKesson Corporation - Strategy, SWOT and Corporate Finance Report Summary McKesson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Essar Oil Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Essar Oil Limited (Essar Oil) is an integrated oil and gas company. The company acquires, explores, develops, and produces oil and gas from its assets. It refines crude oil to produce LPG, naphtha, light diesel oil, Aviation Turbine Fuel (ATF) and kerosene. The company markets its petroleum …
  • Nedbank Group Ltd (NED):企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆